JamesOArmitageMD

Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine

Dr. Armitage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
988102 Nebraska Medical Ctr
Omaha, NE 68198
Phone+1 402-559-9800

Fax+1 402-559-4835

University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1976 - 1977
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1975 - 1976
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1973 - 1975
University of Nebraska College of MedicineClass of 1973

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FASCO) American Society of Clinical Oncologists, 2007

PubMed

3112 citations
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P. Hans, Dennis D. Weisenburger, Timothy C. Greiner, Randy D. Gascoyne, Jan Delabie
Blood. 2004-01-01
360 citations
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
Javeed Iqbal, George E. Wright, Chao Wang, Andreas Rosenwald, Randy D. Gascoyne
Blood. 2012-11-16
60 citations
Lymphomatoid Papulosis: A T-Cell Dyscrasia with a Propensity To Transform into Malignant Lymphoma
Fernando Cabanillas, James Armitage, William C. Pugh, Dennis Weisenburger, Madeleine Duvic
Annals of Internal Medicine. 1995-02-01

Journal Articles

Abstracts/Posters

The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution Experience
James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)
James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)
James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study ShowsOctober 16th, 2024
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s LymphomaOctober 16th, 2024
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's LymphomaOctober 16th, 2024
Join now to see all